Evidence map›Paper›PMID 40901003›Full record

ArticleFrontiers in cellular and infection microbiology2025

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of

Teerasit Techawiwattanaboon, Thomas Courant, Livia Brunner, Suwitra Sathean-Anan-Kun, Pratomporn Krangvichian, Nutta Iadsee, Yaowarin Nakornpakdee, Noppadon Sangjun, Pat Komanee, Nicolas Collin and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Teerasit TechawiwattanaboonDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Thomas CourantVaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
Livia BrunnerVaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
Suwitra Sathean-Anan-KunDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pratomporn KrangvichianChula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand.
Nutta IadseeChula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand.
Yaowarin NakornpakdeeDepartment of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Noppadon SangjunLaboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Pat KomaneeLaboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Nicolas CollinVaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
Kiat RuxrungthamChula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand.
Kanitha PatarakulDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcimb.2022.918629.].

Indexed as

adjuvant formulationimmunoglobulin-like protein ALeptospiraneutral liposomeQS21 saponinQuilA saponinsqualene-in-water emulsionsubunit vaccine

Identifiers

PMID40901003
PMCPMC12400854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.